How to Register an OTC Drug with the FDA
The monograph pathway vs an NDA, the step-by-step registration process, Drug Facts labeling, and the OMUFA fees companies forget.
Key Takeaways
- Monograph = no premarket approval — if the product fits it; otherwise an NDA is needed.
- You still register + list — establishment registration (Part 207) and an NDC per product.
- Drug Facts labeling — the standardized OTC panel (21 CFR 201.66).
- OMUFA fees apply — the annual OTC monograph facility fee.
- Foreign firms need a U.S. Agent — and annual renewal (Oct–Dec).
- Registration ≠ approval — monograph compliance isn't "FDA-approved" either.
Do OTC Drugs Need FDA Approval?
Usually not — but only because of the monograph system. An OTC monograph defines the conditions under which a class of non-prescription drugs is generally recognized as safe and effective (GRASE): the acceptable active ingredients, concentrations, dosage forms, and labeling. A product that fits its monograph can be marketed without a new-drug application. Since the CARES Act (2020) reform (section 505G), monographs run through "deemed final orders" and an administrative-order process.
Step-by-Step OTC Drug Registration
- Confirm it's an OTC drug & find the pathway — classify the product and determine monograph vs NDA
- Confirm monograph compliance — active ingredients, concentrations, dosage form, and labeling fit the applicable monograph
- Obtain DUNS & FEI — the identifiers FDA registration and listing require
- Complete drug establishment registration — the facility, under 21 CFR Part 207
- Get a labeler code & submit the NDC listing — list each product in SPL via eDRLS
- Finalize a compliant Drug Facts label — per 21 CFR 201.66
- Ensure cGMP — manufacture under 21 CFR Parts 210 & 211
- Pay OMUFA facility fees — the annual OTC monograph user fee
- Designate a U.S. Agent — if the facility is foreign (21 CFR 207.69)
- Maintain the annual renewal — every October–December (21 CFR 207.29)
Drug Facts, OMUFA & the Categories
- Drug Facts label (21 CFR 201.66) — the standardized OTC panel: active ingredients & purpose, uses, warnings, directions, other information, inactive ingredients — in the required format
- OMUFA facility fee — an annual cost for OTC monograph drug facilities that companies from cosmetics/supplements often don't anticipate
- Common OTC categories — sunscreens, pain relievers, cough/cold & allergy, antacids, topical antiseptics/first-aid, anti-dandruff, acne
- Monograph reform — the 505G administrative-order system is how FDA now updates monographs (and adds ingredients)
Common OTC Registration Mistakes
- Misclassifying the product — treating an OTC drug as a cosmetic or dietary supplement
- Ingredients/claims outside any monograph — with no NDA to back them
- Incomplete registration or unconfirmed U.S. Agent — leaving the registration invalid
- SPL/NDC listing errors — that stall or reject the listing
- Non-compliant Drug Facts labeling — a top misbranding trigger
- Forgetting OMUFA fees or the annual renewal — causing a lapse or fee delinquency
Register Your OTC Drug the Right Way
FDA Registration Assistance manages the whole OTC pathway — confirming the monograph-vs-NDA route, DUNS/FEI, establishment registration, labeler code and NDC listing (SPL/eDRLS), Drug Facts label review, U.S. Agent for foreign firms, OMUFA and cGMP guidance, and annual renewal — so your OTC drug is compliant before you manufacture, label, list, import, or sell.
Contact us at info@fdaregistrationassistance.com or call +1 (928) 275-8333 for a quote. An independent compliance firm serving 1,000+ companies across 135+ countries, with 15+ years of experience.
Frequently Asked Questions — Registering an OTC Drug
1. Do OTC drugs require FDA approval?
Most don't — if they comply with an applicable OTC monograph. An OTC monograph is FDA's "recipe book" for a category of non-prescription drugs: it sets the permitted active ingredients, concentrations, dosage forms, and labeling. A product that fits its monograph can be marketed without premarket approval. A product that doesn't fit any monograph needs an approved new drug application (NDA/ANDA). Either way, the establishment still registers and each product is still listed.
2. What is an OTC monograph?
An OTC monograph defines the conditions under which a class of OTC drugs is generally recognized as safe and effective (GRASE) and can be marketed without a new-drug application — the acceptable active ingredients, concentrations, dosage forms, and required labeling. Since the CARES Act (2020) reformed the system (section 505G), monographs are administered through "deemed final orders" and an administrative-order process rather than old-style rulemaking. Common monograph categories include sunscreens, pain relievers, antacids, cough/cold, antiseptics, and allergy products.
3. What are the steps to register an OTC drug?
In order: (1) confirm the product is an OTC drug and identify its regulatory pathway (monograph vs NDA); (2) confirm formulation and labeling comply with the applicable monograph; (3) obtain a DUNS number and FEI; (4) complete drug establishment registration (21 CFR Part 207); (5) obtain a labeler code and submit the NDC drug listing in SPL; (6) finalize a compliant Drug Facts label; (7) ensure cGMP; (8) pay OMUFA facility fees; (9) designate a U.S. Agent if foreign; and (10) maintain the annual renewal. Steps can overlap, but all must be in place before marketing.
4. Do I need to register my facility with the FDA?
Yes. Manufacturers, packers, and relabelers of OTC drugs must complete drug establishment registration under 21 CFR Part 207, and foreign facilities must also designate a U.S. Agent. Registration identifies your facility (with an FEI) in FDA's system; it's separate from listing your products and separate from any monograph pathway — all of which have to be handled.
5. What is drug listing and the NDC for an OTC drug?
Each OTC drug product must be listed with FDA and assigned a National Drug Code (NDC) — a unique identifier — submitted electronically in Structured Product Labeling (SPL) format via FDA's eDRLS. The labeler code forms the first part of the NDC and identifies the firm responsible for the product. Registration covers the facility; listing covers each product; both must be kept current.
6. What is a DUNS number and why is it required?
A DUNS (Data Universal Numbering System) number from Dun & Bradstreet identifies the establishment and is required as part of FDA drug registration; FDA also assigns an FEI (Facility Establishment Identifier). Getting the DUNS and FEI right at the start prevents validation errors that can stall registration or the NDC listing.
7. What labeling does an OTC drug need?
A standardized Drug Facts panel (21 CFR 201.66): active ingredients and their purpose, uses, warnings, directions, other information, and inactive ingredients, in the required format and order. The label must not be false or misleading, and any claims must fit the product's monograph or approval. Improper Drug Facts labeling is one of the most common reasons OTC drugs are found misbranded.
8. What is OMUFA and do OTC drugs pay it?
OMUFA is the OTC Monograph User Fee program: manufacturers of OTC monograph drugs pay an annual facility fee to FDA. It's a recurring cost of being in the OTC drug business that companies coming from cosmetics or supplements often don't anticipate. Budgeting for OMUFA is part of planning an OTC launch.
9. Do foreign companies need a U.S. Agent for OTC drugs?
Yes. A foreign OTC drug establishment must designate a U.S. Agent (21 CFR 207.69) as part of registration — the U.S.-based contact for FDA communications, including emergencies, and for assisting with inspections. Without a valid U.S. Agent the registration isn't valid, and the establishment's products can be refused at the border.
10. How often is OTC drug registration renewed?
Annually, between October 1 and December 31 (21 CFR 207.29) — drug registration is annual, unlike food facility registration, which is biennial. Drug listings are also updated (June and December) as needed. A lapsed registration makes the products misbranded and subject to detention, so the annual renewal is part of ongoing compliance, not a one-time task.
11. Does registering an OTC drug mean it's FDA-approved?
No. Registration identifies your facility; listing identifies your product; monograph compliance means the product can be marketed without an NDA. None of these is FDA "approval." Claiming a monograph OTC drug is "FDA-approved" — or that registration/an NDC implies approval — is misbranding (21 CFR 207.77). It's compliance, not approval.
12. What if my OTC product doesn't fit a monograph?
Then the monograph pathway isn't available and the product generally needs an approved new drug application (NDA) — a full premarket review of safety and effectiveness — or you reformulate/relabel to fit an existing monograph. Determining this early is critical: building a product around ingredients or claims outside any monograph, assuming it's "just OTC," leads to enforcement and delays.
13. Which products are OTC drugs?
Non-prescription drugs sold directly to consumers: sunscreens, pain relievers, cough/cold and allergy products, antacids, topical antiseptics and first-aid products, anti-dandruff and acne treatments, and more. Many are sold by beauty, skincare, or wellness brands — which is exactly why companies sometimes misclassify a drug as a cosmetic or supplement. Sunscreen is a common example that's an OTC drug, not a cosmetic.
14. What are the most common OTC registration mistakes?
Misclassifying the product (treating an OTC drug as a cosmetic or supplement); building a formula or claims outside any monograph; incomplete establishment registration or an unconfirmed U.S. Agent; SPL/NDC listing errors; non-compliant Drug Facts labeling; and overlooking OMUFA fees or the annual renewal. Most are avoidable by settling the pathway and the label before manufacturing.
15. How long does OTC drug registration take?
It depends on the product's complexity and how ready the documentation is — the DUNS/FEI, the monograph determination, the label, and the SPL listing all have to be in order. The registration and listing submissions themselves are electronic; the time-consuming part is usually getting the formulation, labeling, and pathway right first. Preparing these before you're up against a launch or import date is the way to avoid delays.
16. How does FDA Registration Assistance help register an OTC drug?
We manage the full OTC pathway: confirming classification and the monograph-vs-NDA route, DUNS/FEI, drug establishment registration, labeler code and NDC listing (SPL/eDRLS), Drug Facts label review, U.S. Agent for foreign firms, guidance on OMUFA and cGMP expectations, and annual renewal — so your OTC drug is compliant before you manufacture, label, list, import, or sell. We're an independent compliance firm serving 1,000+ companies across 135+ countries with 15+ years of experience. Contact info@fdaregistrationassistance.com or +1 (928) 275-8333.
